{"id":249067,"date":"2021-02-05T10:15:31","date_gmt":"2021-02-05T10:15:31","guid":{"rendered":"http:\/\/acikgazete.com\/?p=249067"},"modified":"2021-02-05T10:15:31","modified_gmt":"2021-02-05T10:15:31","slug":"guney-koreli-uzmanlar-astrazeneca-asisina-karsi-uyardi","status":"publish","type":"post","link":"https:\/\/acikgazete.com\/guney-koreli-uzmanlar-astrazeneca-asisina-karsi-uyardi\/","title":{"rendered":"G\u00fcney Koreli uzmanlar AstraZeneca a\u015f\u0131s\u0131na kar\u015f\u0131 uyard\u0131"},"content":{"rendered":"
G\u00fcney Kore’de uzmanlar\u0131n, AstraZeneca a\u015f\u0131s\u0131n\u0131n 65 ya\u015f\u0131n \u00fczerindeki insanlar\u0131n kullanmas\u0131 konusunda ‘veri eksikli\u011fi nedeniyle’ uyar\u0131da bulunduklar\u0131 a\u00e7\u0131kland\u0131.<\/p>\n
Kore G\u0131da ve \u0130la\u00e7 G\u00fcvenli\u011fi Bakanl\u0131\u011f\u0131, cuma g\u00fcn\u00fc yapt\u0131\u011f\u0131 a\u00e7\u0131klamada, G\u00fcney Koreli dan\u0131\u015fmanlardan olu\u015fan bir heyetin, 65 ya\u015f \u00fcst\u00fc ki\u015filer i\u00e7in AstraZeneca\u2019n\u0131n kullan\u0131lmas\u0131 konusunda uyar\u0131da bulundu\u011funu a\u00e7\u0131klad\u0131.<\/p>\n
G\u00fcney Kore taraf\u0131ndan onaylanan ilk a\u015f\u0131 olmas\u0131 beklenen AstraZeneca i\u00e7in yap\u0131lan bu tavsiyenin ise, sa\u011fl\u0131k \u00e7al\u0131\u015fanlar\u0131na ve ya\u015fl\u0131lara \u00f6ncelik verilen bir a\u015f\u0131lama program\u0131n\u0131 karma\u015f\u0131kla\u015ft\u0131rabilece\u011fi belirtiliyor.<\/p>\n
Ulusal ila\u00e7 komisyonu, 18 ya\u015f\u0131ndan b\u00fcy\u00fckler i\u00e7in a\u015f\u0131y\u0131 onaylasa da, Ulusal G\u0131da ve \u0130la\u00e7 G\u00fcvenli\u011fi De\u011ferlendirme Enstit\u00fcs\u00fc m\u00fcd\u00fcr\u00fc Lee Dong-hee yap\u0131lan a\u00e7\u0131klamada, a\u015f\u0131n\u0131n 65 ya\u015f\u0131n \u00fczerindekiler i\u00e7in kullan\u0131lmas\u0131 konusunda uyar\u0131da bulunuldu\u011fu belirtildi.<\/p>\n
Lee ayr\u0131ca, karar al\u0131n\u0131rken deniza\u015f\u0131r\u0131 \u00fclkelerde al\u0131nan benzer kararlar\u0131n da dikkate al\u0131naca\u011f\u0131n\u0131 belirterek “Heyet, a\u015f\u0131y\u0131 Avrupa’n\u0131n \u00f6nerdi\u011fi gibi 18 ya\u015f\u0131n \u00fczerindeki ki\u015filere vermeyi tavsiye etti, ancak hen\u00fcz yeterli veri toplanmad\u0131\u011f\u0131 i\u00e7in 65 ya\u015f\u0131n \u00fczerindekileri a\u015f\u0131lama konusunda ihtiyatl\u0131 olunmas\u0131n\u0131 tavsiye etti” ifadelerini kulland\u0131.<\/p>\n
Ayn\u0131 \u015fekilde, baz\u0131 Avrupa \u00fclkeleri de ‘veri eksikli\u011fi nedeniyle’ a\u015f\u0131y\u0131 gen\u00e7lerle s\u0131n\u0131rland\u0131rma y\u00f6n\u00fcnde karar alm\u0131\u015ft\u0131.<\/p>\n
AstraZeneca ile 20 milyon dozluk iki y\u00f6nl\u00fc sat\u0131n alma anla\u015fmas\u0131 imzalayan G\u00fcney Kore, a\u015f\u0131n\u0131n ilk partisini bu ay ba\u015f\u0131nda teslim ald\u0131. \u015eirket, a\u015f\u0131n\u0131n acil kullan\u0131m onay\u0131 i\u00e7in 4 ocakta ba\u015fvuruda bulunmu\u015ftu. (Sputnik)<\/p>\n
G\u00fcney Kore’de uzmanlar\u0131n, AstraZeneca a\u015f\u0131s\u0131n\u0131n 65 ya\u015f\u0131n \u00fczerindeki insanlar\u0131n kullanmas\u0131 konusunda ‘veri eksikli\u011fi nedeniyle’ uyar\u0131da bulunduklar\u0131 a\u00e7\u0131kland\u0131. Kore G\u0131da ve \u0130la\u00e7 G\u00fcvenli\u011fi Bakanl\u0131\u011f\u0131, cuma g\u00fcn\u00fc yapt\u0131\u011f\u0131 a\u00e7\u0131klamada, G\u00fcney Koreli dan\u0131\u015fmanlardan olu\u015fan bir heyetin, 65 ya\u015f \u00fcst\u00fc ki\u015filer i\u00e7in AstraZeneca\u2019n\u0131n kullan\u0131lmas\u0131 konusunda uyar\u0131da bulundu\u011funu a\u00e7\u0131klad\u0131. G\u00fcney Kore taraf\u0131ndan onaylanan ilk a\u015f\u0131 olmas\u0131 beklenen AstraZeneca i\u00e7in yap\u0131lan […]<\/p>\n